Literature DB >> 11168329

Autonomic neuropathy--a complication less pronounced in patients with Type 1 diabetes mellitus who have lower blood glucose levels.

P Reichard1, K Jensen-Urstad, M Ericsson, M Jensen-Urstad, L E Lindblad.   

Abstract

AIMS: Autonomic neuropathy is a serious diabetic complication, probably contributing to the death of many young people with Type 1 diabetes mellitus. It is often not diagnosed.
METHODS: Patients with Type 1 diabetes from the Stockholm Diabetes Intervention Study were investigated with power spectral analysis (n = 88), heart rate and blood pressure reactions to tilting (n = 66), and heart rate variability during deep breathing (n = 70) a mean of 11.4 years after randomization to intensified conventional treatment (ICT) or standard treatment (ST), the treatment groups similar with regard to age, duration of diabetes and metabolic control at baseline (HbA1c 9.4 (1.3)%, mean (SD)). Blood glucose levels (mean of 29 HbA1c values) during the 10 years were lower in the patients from the ICT group (7.2 (0.6) vs. 8.3 (1.0)%, P = 0.001).
RESULTS: Heart rate variability (HRV) in the high frequency range (P = 0.034), the expiration-inspiration ratio (P = 0.020), and the brake index during tilt (P = 0.044) were lower in the ST group, indicating more pronounced parasympathetic insufficiency. Systolic blood pressure fell by 10 (16) mmHg in the ST group, and by 2.5 (15) mmHg in the ICT group 8 min after rising from the supine to a 70 degrees upright position (P = 0.034). A decreased autonomic function was associated with age and higher HbA1c.
CONCLUSION: Better autonomic nerve function is associated with lower HbA1c and lower age which were both the same in the intensively and the conventionally treatment groups at baseline. After a mean of 11.4 years autonomic function was better in the intensively treated group.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11168329     DOI: 10.1046/j.1464-5491.2000.00398.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  9 in total

Review 1.  Treatments for diabetic neuropathy.

Authors:  A J Boulton
Journal:  Curr Diab Rep       Date:  2001-10       Impact factor: 4.810

2.  Impact of glycemic control on heart rate variability in youth with type 1 diabetes: the SEARCH CVD study.

Authors:  Mamta Jaiswal; Tasha E Fingerlin; Elaine M Urbina; R Paul Wadwa; Jennifer W Talton; Ralph B D'Agostino; Richard F Hamman; Stephen R Daniels; Santica M Marcovina; Larry M Dolan; Dana Dabelea
Journal:  Diabetes Technol Ther       Date:  2013-09-06       Impact factor: 6.118

Review 3.  Glucose targets for preventing diabetic kidney disease and its progression.

Authors:  Marinella Ruospo; Valeria M Saglimbene; Suetonia C Palmer; Salvatore De Cosmo; Antonio Pacilli; Olga Lamacchia; Mauro Cignarelli; Paola Fioretto; Mariacristina Vecchio; Jonathan C Craig; Giovanni Fm Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2017-06-08

4.  Deep breathing improves blunted baroreflex sensitivity even after 30 years of type 1 diabetes.

Authors:  M Rosengård-Bärlund; L Bernardi; J Holmqvist; G Debarbieri; M Mäntysaari; C-G Af Björkesten; C Forsblom; P-H Groop
Journal:  Diabetologia       Date:  2011-05-03       Impact factor: 10.122

5.  Risk factors and outcomes of intraoperative atrial fibrillation in patients undergoing thoracoscopic anatomic lung surgery.

Authors:  Chaoyang Tong; Qi Zhang; Yuan Liu; Meiying Xu; Jingxiang Wu; Hui Cao
Journal:  Ann Transl Med       Date:  2021-04

6.  Near-normoglycaemia and development of neuropathy: a 24-year prospective study from diagnosis of type 1 diabetes.

Authors:  Dan Ziegler; Margarete Behler; Maria Schroers-Teuber; Michael Roden
Journal:  BMJ Open       Date:  2015-06-24       Impact factor: 2.692

7.  How Does Ambient Air Temperature Affect Diabetes Mortality in Tropical Cities?

Authors:  Xerxes T Seposo; Tran Ngoc Dang; Yasushi Honda
Journal:  Int J Environ Res Public Health       Date:  2017-04-05       Impact factor: 3.390

Review 8.  Obesity, diabetes and atrial fibrillation; epidemiology, mechanisms and interventions.

Authors:  O Asghar; U Alam; S A Hayat; R Aghamohammadzadeh; A M Heagerty; R A Malik
Journal:  Curr Cardiol Rev       Date:  2012-11

Review 9.  Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.

Authors:  Clement Lo; Tadashi Toyama; Ying Wang; Jin Lin; Yoichiro Hirakawa; Min Jun; Alan Cass; Carmel M Hawley; Helen Pilmore; Sunil V Badve; Vlado Perkovic; Sophia Zoungas
Journal:  Cochrane Database Syst Rev       Date:  2018-09-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.